Psychopharmacological evaluation of a new antidepressant: butriptyline.
D000109:Acetylcholine / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000633:toxicity; D001285:Atropine / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D003259:Consummatory Behavior / Q000187:drug effects; D003864:Depression, Chemical; D003986:Dibenzocycloheptenes / Q000494:pharmacology*; D004336:Drug Antagonism; D004357:Drug Synergism; D004924:Escape Reaction / Q000187:drug effects; D000431:Ethanol / Q000494:pharmacology; D006168:Guinea Pigs; D006591:Hexobarbital / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014203:Tremorine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes; D000431:Ethanol; D001285:Atropine; D006632:Histamine; D012110:Reserpine; D006591:Hexobarbital; D000661:Amphetamine; D011398:Promethazine; D000109:Acetylcholine; D007099:Imipramine; D014203:Tremorine